Patents by Inventor Horst-Peter Antonicek

Horst-Peter Antonicek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INSECTICIDAL DERIVATIVES OF SUBSTITUTED BENZYLAMINES
    Publication number: 20110124647
    Abstract: The present invention relates to novel derivatives of substituted benzylamines, to processes for their preparation and to their use for controlling animal pests, especially arthropods, in particular insects.
    Type: Application
    Filed: March 28, 2008
    Publication date: May 26, 2011
    Applicant: Bayer CropScience AG
    Inventors: Christian Arnold, Ulrich Görgens, Hans-Georg Schwarz, Graham Holmwood, Roland Andree, Olga Malsam, Otto Schallner, Eva-Marie Franken, Horst-Peter Antonicek, Stefan Werner
  • Pyrazolopyrimidines
    Patent number: 7781439
    Abstract: Pyrazolopyrimidines of the formula in which R1, R2, R3, R4, R5 and X are as defined in the description, processes for preparing these compounds and their use for controlling unwanted microorganisms.
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: August 24, 2010
    Assignee: Bayer CropScience AG
    Inventors: Stefan Herrmann, Olaf Gebauer, Herbert Gayer, Stefan Hillebrand, Ulrich Heinemann, Oliver Guth, Kerstin Ilg, Thomas Seitz, Ronald Ebbert, Ulrike Wachendorff-Neumann, Peter Dahmen, Karl-Heinz Kuck, Horst-Peter Antonicek
  • CROPWELLLINS AND SYNTHETIC DERIVATIVES THEREOF USED AS MEDICAMENTS
    Publication number: 20090131406
    Abstract: The present invention relates to cripowellins and synthetic derivatives thereof for treating diseases of man and also, in particular, to their use for preparing a medicament for treating cancer or other proliferative disorders in man and animal. Furthermore, the present invention relates to novel cripowellin derivatives and processes for their preparation.
    Type: Application
    Filed: June 13, 2006
    Publication date: May 21, 2009
    Applicant: BAYER CROPSCIENCE AG
    Inventors: Horst-Peter Antonicek, Robert Velten, Peter Jeschke
  • Pyrazolopyrimidines
    Publication number: 20080287463
    Abstract: Pyrazolopyrimidines of the formula in which R1, R2, R3, R4, R5 and X are as defined in the description, processes for preparing these compounds and their use for controlling unwanted microorganisms.
    Type: Application
    Filed: February 7, 2006
    Publication date: November 20, 2008
    Applicant: Bayer CropScience AG
    Inventors: Stefan Herrmann, Olaf Gebauer, Herbert Gayer, Stefan Hillebrand, Ulrich Heinemann, Oliver Guth, Kerstin Ilg, Thomas Seitz, Ronald Ebbert, Ulrike Wachendorff-Neumann, Peter Dahmen, Karl-Heinz Kuck, Horst-Peter Antonicek
  • Helicokinin-receptor from insects
    Publication number: 20050235365
    Abstract: The invention relates to polypeptides having the biological activity of a helicokinin receptor, and to polynucleotides which encode the polypeptides, and in particular to their use for finding active compounds for crop protection.
    Type: Application
    Filed: April 4, 2003
    Publication date: October 20, 2005
    Inventors: Horst-Peter Antonicek, Katrin Schnizler, Marcus Weidler
  • Cyclopentabenzofuran derivatives and their use
    Patent number: 6943182
    Abstract: The invention relates to cyclopentabenzofuran derivatives, process for their preparation, the use of cyclopentabenzofuran derivatives for the production of a medicament for the therapy of NF-?B-dependent diseases and medicaments which contain the cyclopentabenzofuran derivatives.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: September 13, 2005
    Assignee: Bayer Aktiengesellschaft
    Inventors: Walter Guarnieri, Thomas Jaetsch, Andreas Schoop, Jörg Baumgarten, Axel Kretschmer, Horst-Peter Antonicek
  • Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases
    Publication number: 20050075275
    Abstract: The invention relates to the use of APJ receptor agonists for producing a medicament for the treatment and/or prophylaxis of coronary heart diseases, in particular stable and unstable angina pectoris, acute myocardial infarction, myocardial infarction prophylaxis, sudden heart death, heart failure, and high blood pressure and the sequelae of atherosclerosis.
    Type: Application
    Filed: July 24, 2002
    Publication date: April 7, 2005
    Applicant: Bayer Aktiengesellschaft
    Inventors: Barbara Albrecht, Horst-Peter Antonicek, Peter Ellinghaus, Erwin Bischoff
  • Substituted &agr;, &bgr;-anellated butyrolactones
    Patent number: 6723718
    Abstract: The present invention relates to novel substituted &agr;,&bgr;-fused butyrolactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, craniocerebral trauma, states of pain or CNS-mediated spasms.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: April 20, 2004
    Assignee: Bayer Aktiengesellschaft
    Inventors: Andreas Stolle, Horst-Peter Antonicek, Stephen Lensky, Arnd Voerste, Thomas Müller, Jörg Baumgarten, Karsten von dem Bruch, Gerhard Müller, Udo Stropp, Ervin Horváth, Jean-Marie-Viktor de Vry, Rudy Schreiber
  • Substituted alpha, beta-anellated butyrolactones
    Publication number: 20030158424
    Abstract: The present invention relates to novel substituted &agr;,&bgr;-fused butyrolactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, craniocerebral trauma, states of pain or CNS-mediated spasms.
    Type: Application
    Filed: July 25, 2002
    Publication date: August 21, 2003
    Inventors: Andreas Stolle, Horst-Peter Antonicek, Stephen Lensky, Arnd Voerste, Thomas Muller, Jorg Baumgarten, Karsten von dem Bruch, Gerhard Muller, Udo Stropp, Ervin Horvath, Jean-Marie-Viktor de Vry, Rudy Schreiber
  • Cyclopentabenzofuran derivatives and their use
    Publication number: 20030144334
    Abstract: The invention relates to cyclopentabenzofuran derivatives and their use preparation, the use of cyclopentabenzofuran derivatives for the production of a medicament for the therapy of NF-&kgr;B-dependent diseases and medicaments which contain the cyclopentabenzofuran derivatives.
    Type: Application
    Filed: May 30, 2002
    Publication date: July 31, 2003
    Inventors: Walter Guarnieri, Thomas Jaetsch, Andreas Schoop, Jorg Baumgarten, Axel Kretschmer, Horst-Peter Antonicek
  • Use of cyclopentabenzofuran-derivatives for combating (NF-&kgr;B)-dependent diseases
    Patent number: 6518274
    Abstract: The invention relates to the use of cycloventabenzofuran derivatives for the production of a medicament for the treatment of nuclear factor of &kgr;B-dependent diseases.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: February 11, 2003
    Assignee: Bayer Aktiengesellschaft
    Inventors: Matthias Gehling, Jörg Baumgarten, Axel Kretschmer, Horst-Peter Antonicek, Peter Proksch, Bambang Wahyu Nugroho, Frank Bohnenstengel
  • Substituted &agr;, &bgr;-anellated butyrolactones
    Patent number: 6462074
    Abstract: The present invention relates to novel substituted (&agr;,&bgr;-fused butyrolactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, craniocerebral trauma, states of pain or CNS-mediated spasms.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: October 8, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Andreas Stolle, Horst-Peter Antonicek, Stephen Lensky, Arnd Voerste, Thomas Müller, Jörg Baumgarten, Karsten von dem Bruch, Gerhard Müller, Udo Stropp, Ervin Horváth, Jean-Marie-Viktor de Vry, Rudy Schreiber
  • Substituted &bgr;,&ggr;-anellated lactones
    Patent number: 6433004
    Abstract: The present invention relates to novel substituted &bgr;,&ggr;-fused lactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, craniocerebral trauma, states of pain or CNS-mediated spasms.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: August 13, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Andreas Stolle, Horst-Peter Antonicek, Stephen Lensky, Arnd Voerste, Thomas Müller, Jörg Baumgarten, Karsten von dem Bruch, Gerhard Müller, Udo Stropp, Ervin Horváth, Jean-Marie-Viktor de Vry, Rudy Schreiber
  • Receptor for latrotoxin from insects
    Publication number: 20020106723
    Abstract: The invention relates to polypeptides having the biological activity of latrotoxin receptors, and to nucleic acids encoding these polypeptides, and in particular to their use for finding active compounds for crop protection.
    Type: Application
    Filed: March 14, 2001
    Publication date: August 8, 2002
    Inventors: Horst-Peter Antonicek, Gabi Friedrich, Thomas Schulte
  • Cyclopentabenzofuran derivatives and their use
    Patent number: 6420393
    Abstract: The invention relates to cyclopentabenzofuran derivatives, processes for their preparation, the use of cyclopentabenzofuran derivatives for the production of a medicament for the therapy of NF-&kgr;B-dependent diseases and medicaments which contain the cyclopentabenzofuran derivatives.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: July 16, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Walter Guarnieri, Thomas Jaetsch, Andreas Schoop, Jörg Baumgarten, Axel Kretschmer, Horst-Peter Antonicek
  • Receptors for peptides from insects
    Publication number: 20020056151
    Abstract: The invention relates to polypeptides having the biological activity of peptide receptors, and to nucleic acids encoding these polypeptides, and in particular to their use for finding active compounds for crop protection.
    Type: Application
    Filed: March 12, 2001
    Publication date: May 9, 2002
    Inventors: Horst-Peter Antonicek, Gabi Friedrich, Thomas Schulte
  • Substituted bicyclic lactones
    Patent number: 6376539
    Abstract: The present invention relates to novel substituted bicyclic lactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, cranial cerebral trauma, states of pain or CNS-mediated spasms.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: April 23, 2002
    Assignee: Bayer Aktiengesellschaft
    Inventors: Andreas Stolle, Horst-Peter Antonicek, Stephen Lensky, Arnd Voerste, Thomas Müller, Jörg Baumgarten, Karsten von dem Bruch, Gerhard Müller, Udo Stropp, Ervin Horváth, Jean-Marie-Viktor de Vry, Rudy Schreiber
  • Use of efomycins
    Patent number: 6291515
    Abstract: The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: September 18, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst-Peter Antonicek, Erwin Bischoff, Daniel Gondol, Oliver Gutbrod, Thomas Krahn, Maria-Luisa Rodriguez, Helmuth Schütz
  • Sugar-modified cytostatics
    Patent number: 6271342
    Abstract: The invention relates to cytostatics which, by modification with sugar, are tumor-specific. Suitable spacers ensure serum stability and at the same time an intracellular action.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: August 7, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hans-Georg Lerchen, Karsten von dem Bruch, Uwe Petersen, Jörg Baumgarten, Norbert Piel, Horst-Peter Antonicek, Walter Weichel, Michael Sperzel, Klaus Dieter Bremm
  • Use of efomycins
    Patent number: 6225337
    Abstract: The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: May 1, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst-Peter Antonicek, Erwin Bischoff, Daniel Gondol, Oliver Gutbrod, Thomas Krahn, Maria-Luisa Rodriguez, Helmuth Schütz